Akrimax Pharmaceuticals   Report issue

For profit Phase 4
Founded: Cranford NJ United States (2002)
Status: No NME R&D (2002)

Organization Overview

First Clinical Trial
2017
NCT02946918
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

AKRIMAX PHARMS

Active Ingredients

Marketed Drugs (1)

propranolol (inderal) (1973)

Drugs in Phase 4 Trials (1)

levothyroxine (Synthroid) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypothyroidism (Phase 4)

Thyroid Diseases (Phase 4)

Thyroid Neoplasms (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1